PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Breakthroughs in Primary Hyperoxaluria Type 1: Insights to Prompt Diagnosis and Optimize Treatment
Visit https://www.peervoice.com/ZMD860 to view the entire programme with slides. After completing “Breakthroughs in Primary Hyperoxaluria Type 1: Insights to Prompt Diagnosis and Optimize Treatment”, participants will be able to: Discuss the clinical burden of primary hyperoxaluria type 1 (PH1) and the impact of missed diagnosis; Outline key clinical manifestations that should prompt investigation and genetic testing to confirm diagnosis; and Evaluate the latest clinical evidence with pharmacologic approaches to treat PH1.